Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Crossref DOI link: https://doi.org/10.1007/s40121-016-0119-9
Published Online: 2016-07-01
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deck, Daniel H.
Jordan, Jennifer M.
Holland, Thomas L.
Fan, Weihong
Wikler, Matthew A.
Sulham, Katherine A.
Ralph Corey, G.
Funding for this research was provided by:
The Medicines Co.
